Drach J, McQueen T, Zhao S, Robertson KA, Collins SJ, Malvasi F, Andreeff M , Mehta K
GLP-1: An emergent wonder anti-aging and longevity drug
In addition, cagrilintide is now being developed in combination with the GLP-1 agonist semaglutide as CagriSema to achieve sustained weight loss in persons with overweight and obesity
Doctors often recommend follow-up treatments along with healthy skin habits to prolong visible effects
GLP-1 receptor agonists like Ozempic and Victoza were originally developed to treat type 2 diabetes, but their weight loss effects were quickly discovered
Supports the reduction of skin discoloration, helping to enhance your natural glow and radiance